| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68c213ba9952360f439567152e047b18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1916cbc3943c56f9c2e5daf9c5b37a4a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2576-023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H30-40 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0478
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0476
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0459
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-044 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 |
| filingDate |
2017-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a65d95b59a506a7ebcbfe76806f639cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_046ab19924c42ae454ca7ffab7d83f50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84af7971620438bebb2fdce64243a2ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73cfb671b1bc7575f018e21881ad5aef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4ae9bb2420c02c9b3e03f0548fd4d60 |
| publicationDate |
2018-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018177901-A1 |
| titleOfInvention |
Evaluation of presence of and vulnerability to atrial fibrillation and other indications using matrix metalloproteinase-based imaging |
| abstract |
The invention provides, in some embodiments, methods relating to assessing increased risk of developing atrial fibrillation (AF), and/or the likelihood of responding to particular AF therapies using imaging agents comprising an MMP inhibitor linked to an imaging moiety. The invention further provides methods for evaluating the presence of the risk of developing other cardiovascular conditions and assessing the effectiveness of treatment or other intervention for such conditions by determining MMP levels. |
| priorityDate |
2011-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |